Rigel Pharmaceuticals, Inc.
NASDAQ:RIGLBiotechnology
Healthcare
$42.92 -1.86%
-$0.62 today
- Market cap
- $808.18M
- Beta
- 1.18
- P/E (TTM)
- 1.7
- EPS (TTM)
- $19.78
52W Low $18.14High $52.24
Volume 0.24M
Average 0.36M
Price history
Rigel Pharmaceuticals, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-7.14%
Period high
$51.45
Period low
$25.44
Latest
$42.92
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| S-8 | Aug 4, 2026 | Aug 4, 2026 | |
| 8-K | Aug 4, 2026 | Aug 4, 2026 | |
| 10-Q | Aug 4, 2026 | Aug 4, 2026 | |
| 4 | Jul 10, 2026 | Jul 10, 2026 | |
| 8-K | Jul 1, 2026 | Jul 1, 2026 |
Competitors
Who does Rigel Pharmaceuticals, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about RIGL's filings, answered from its disclosures.
What is the latest RIGL filing?
The latest filing shown is SC 13G dated Nov 13, 2026.
How many recent filings does RIGL have?
Intrinsic Alpha currently shows 20 recent filings for RIGL.
Continue the stock analysis
Jump to another research area for this company.